NEWS & EVENTS
HIV/AIDS-related HLBS Research Webinar Series: "Myeloid Cell Activation: A Potential Contributor to CVD Risk in HIV Infection?"
Webinar
Description

The NHLBI HIV/AIDS-related heart, lung, blood, and sleep (HLBS) research webinar series serves to highlight state-of-the-art research from experts in the field and provide a platform for disseminating pertinent NHLBI HIV/AIDS-related research funding opportunity announcements.

Time: 1:00pm - 2:00pm (EST)

Select Speakers
Dr. Funderburg is a tenured Associate Professor in the School of Health and Rehabilitation Sciences at the Ohio State University Wexner Medical Center. He is involved in the AIDS Clinical Trials Group (ACTG), and has worked on several national clinical trials aimed at reducing chronic immune activation and inflammation in people living with HIV; his lab also contributed to the highly successful single site trial (SATURN-HIV), led by Dr. Grace McComsey at Case Western Reserve University, that explored the immune-modulatory effects of rosuvastatin on ART treated HIV-infected individuals. Overall, the goal of the Funderburg lab is to perform clinically relevant research and to train translational scientists capable of bridging the gap between the lab and the clinic.
Associate Professor at Ohio State University
Dr. Funderburg is an Associate Professor in the School of Health and Rehabilitation Sciences at the Ohio State University Wexner Medical Center. He is involved in the AIDS Clinical Trials Group (ACTG), worked on several national clinical trials, and has the Funderburg lab.
Nicholas Funderburg, PhD